![]() i2o Therapeutics i2o Therapeutics is a company that develops an ionic liquid technology intended to develop the effective oral formulation. | ![]() Virogenics Virogenics is a company that specializes in the research and development of gene therapies and stem cell technology. | ![]() CervoMed CervoMed (formerly known as Diffusion Pharmaceuticals) is a drug-discovery and development company. | |||
Founding Date | Founding Date 2019 | Founding Date 2015 | Founding Date 2003 | Founding Date 2001 | Founding Date 2020 |
Type | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Waltham, US HQ | Locations San Diego, US HQ | Locations Charlottesville, US HQ | Locations Cambridge, US HQ Boston, US |
Employees | Employees 713% decrease | Employees 76 | Employees 4 | Employees 10 | Employees 67 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.9 b | Valuation ($) N/A | Valuation ($) 111.3 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $521k (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $4m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($152.1m) (FY, 2023) | Net income N/A | Net income ($27m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 4m (about 6 years ago) | Latest funding round N/A | Latest funding round $ 6m (over 13 years ago) | Latest funding round N/A | Latest funding round $ 150m (about 4 years ago) |
Total funding raised | Total funding raised $ 4m | Total funding raised $ 131.5m | Total funding raised $ 6m | Total funding raised N/A | Total funding raised $ 236m |

Morphic Therapeutic operates as a biotechnology company.
View company
Virogenics is a company that specializes in the research and development of gene therapies and stem cell technology.
View company
CervoMed (formerly known as Diffusion Pharmaceuticals) is a drug-discovery and development company.
View company
MOMA Therapeutics is a biotechnology company.
View company